1 unchanged sentence
Rule 10b5-1 Trading Plans
−Removed: During the three months ended September 30, 2025, none of our directors
+Added: During the three months ended March 31, 2026, none of our directors
or officers adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined
in Item 408 of Regulation S-K).
+Added: Articles of Incorporation of AMHN, Inc.
+Added: filed in the State of Nevada, dated July 20, 2010 (1)
+Added: Bylaws of AMHN, Inc.
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a)
6 unchanged sentences
Furnished herewith.
+Added: Filed as an exhibit to Form 10-Q for the quarter ended June 30, 2010 filed with the Commission on August 3, 2010 and incorporated herein by reference (SEC File No.
+Added: Filed as an exhibit to Definitive 14C Information Statement filed with the Commission on June 29, 2010 and incorporated herein by reference (SEC File No.
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: November 12, 2025
TherapeuticsMD, Inc.
−Removed: /s/ Marlan D.
Chief Executive Officer
(Principal Executive Officer)
−Removed: /s/ Joseph Ziegler
Joseph Ziegler
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.